title: Labile conjugation of a hydrophilic drug to PLA oligomers to modify a drug delivery system: cephradin in a PLAGA matrix.
abstract: The physical entrapment of a hydrophilic drug within degradable microspheres is generally difficult because of poor entrapment yield and/or fast release, depending on the microsphere fabrication method. In order to counter the effects of drug hydrophilicity, it is proposed to covalently attach the drug to lactic acid oligomers, with the aim of achieving temporary hydrophobization and slower release controlled by the separation of the drug from the degradable link within the polymer matrix. This strategy was tested on microspheres of the antibiotic cephradin. As the prodrug form, the entrapment of the drug was almost quantitative. The prodrug did degrade in an aqueous medium, modelling body fluids, but cleavage did not occur at the drug-oligomer junction and drug molecules bearing two lactyl residual units were released. When the prodrug is entrapped within a PLAGA matrix, no release was observed within the experimental time period. However, data suggest that conjugation via a bond more sensitive to hydrolysis than the main chain PLA ester bonds should make the system work as desired.
authors.affiliation: CRBA-UMR CNRS 1465, Faculty of Pharmacy, University Montpellier 1, France.
authors.forename: C
authors.initials: C
authors.lastname: Ustariz-Peyret
authors.forename: J
authors.initials: J
authors.lastname: Coudane
authors.forename: M
authors.initials: M
authors.lastname: Vert
authors.forename: V
authors.initials: V
authors.lastname: Kaltsatos
authors.forename: B
authors.initials: B
authors.lastname: Boisramené
mesh_terms: D001673:Biodegradation, Environmental; D002214:Capsules; D002515:Cephradine / Q000008:administration & dosage* / Q000494:pharmacology; D003692:Delayed-Action Preparations; D004339:Drug Compounding / Q000379:methods*; D016503:Drug Delivery Systems; D004926:Escherichia coli / Q000187:drug effects; D066298:In Vitro Techniques; D019344:Lactic Acid; D011100:Polyglycolic Acid; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers; D013211:Staphylococcus aureus / Q000187:drug effects
chemical_list: D002214:Capsules; D003692:Delayed-Action Preparations; D011108:Polymers; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; D002515:Cephradine